CatenaBio
Berkeley, US · Founded 2020 · 19 employees on LinkedIn · 3 known investors
Find your way into CatenaBio
374 people in our graph share verified history with the CatenaBio team — schools, employers, funds. One of them is your warm intro.
Scott Davisunlockedknows Marco Lobba · together at University of California, Berkeley (overlapped)
×11knows the team · via University of California, Berkeley
CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells. The company partners with pharmaceutical firms to advance development of novel therapeutic modalities.
Founders & leadership
CatenaBio was founded in 2020 by Marco Lobba, Ph.D..
ML
Investors · 3
Frequently asked questions
- What does CatenaBio do?
- CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells. The company partners with pharmaceutical firms to advance development of novel therapeutic modalities.
- Who founded CatenaBio?
- CatenaBio was founded by Marco Lobba, Ph.D. in 2020.
- Who are CatenaBio's investors?
- CatenaBio's investors include FREEFLOW, LongeVC, NYBC Ventures.
- Where is CatenaBio headquartered?
- CatenaBio is headquartered in Berkeley, US.